Celularity (CELUW) Intangibles (2020 - 2025)
Celularity (CELUW) reported Intangibles of $7.8 million for Q4 2025, down 16.13% year-over-year from $9.2 million in Q4 2024, and down 4.62% quarter-over-quarter from $8.1 million in Q3 2025.
Celularity (CELUW) Intangibles (2020 - 2025) Analysis & Trends
Celularity (CELUW) has 6 years of Intangibles data on file, last reported at $7.8 million in Q4 2025.
- Intangibles for Q4 2025 came in at $7.8 million, down 16.13% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.8 million (down 16.13% YoY), and the FY2025 annual result was $7.8 million, down 16.13% from the prior year.
- Intangibles fell to $7.8 million in Q4 2025 per CELUW's latest filing, from $8.1 million in the prior quarter.
- Over five years, Intangibles peaked at $123.7 million in Q3 2021 and troughed at $700000.0 in Q2 2023.
- A 5-year average of $38.2 million and a median of $11.3 million in 2023 frame the typical range for Intangibles.
- The sharpest annual moves came in 2023 and 2025: Intangibles slumped 99.35% in 2023, then soared 3327.57% in 2025.
- A 5-year view of Intangibles shows it stood at $123.2 million in 2021, then retreated by 11.92% to $108.5 million in 2022, then sank by 89.86% to $11.0 million in 2023, then retreated by 15.93% to $9.2 million in 2024, then fell by 16.13% to $7.8 million in 2025.
- Business Quant data shows CELUW's Intangibles at $7.8 million in Q4 2025, $8.1 million in Q3 2025, and $24.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Celularity | - | - | -3.27 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.76 Mn |
| Sep 30, 2025 | 8.13 Mn |
| Jun 30, 2025 | 23.99 Mn |
| Mar 31, 2025 | 700,000.00 |
| Dec 31, 2024 | 9.25 Mn |
| Sep 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 700,000.00 |
| Dec 31, 2023 | 11.00 Mn |
| Sep 30, 2023 | 11.55 Mn |
| Jun 30, 2023 | 700,000.00 |
| Mar 31, 2023 | 11.95 Mn |
| Dec 31, 2022 | 108.50 Mn |
| Sep 30, 2022 | 121.55 Mn |
| Jun 30, 2022 | 108.50 Mn |
| Mar 31, 2022 | 14.15 Mn |
| Dec 31, 2021 | 123.19 Mn |
| Sep 30, 2021 | 123.74 Mn |
| Dec 31, 2020 | 16.88 Mn |